Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.
Hayes P, Fernandez N, Ochsenbauer C, Dalel J, Hare J, King D, Black L, Streatfield C, Kakarla V, Macharia G, Makinde J, Price M, Hunter E; IAVI protocol C investigators; Gilmour J. Hayes P, et al. Among authors: king d. PLoS One. 2021 Nov 17;16(11):e0260118. doi: 10.1371/journal.pone.0260118. eCollection 2021. PLoS One. 2021. PMID: 34788349 Free PMC article.
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.
Fernandez N, Hayes P, Makinde J, Hare J, King D, Xu R, Rehawi O, Mezzell AT, Kato L, Mugaba S, Serwanga J, Chemweno J, Nduati E, Price MA, Osier F, Ochsenbauer C, Yue L, Hunter E, Gilmour J; IAVI protocol C investigators. Fernandez N, et al. Among authors: king d. Front Immunol. 2022 Dec 1;13:1029029. doi: 10.3389/fimmu.2022.1029029. eCollection 2022. Front Immunol. 2022. PMID: 36532063 Free PMC article.
A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection.
Makinde J, Nduati EW, Freni-Sterrantino A, Streatfield C, Kibirige C, Dalel J, Black SL, Hayes P, Macharia G, Hare J, McGowan E, Abel B, King D, Joseph S; IAVI Protocol C Investigators; Hunter E, Sanders EJ, Price M, Gilmour J. Makinde J, et al. Among authors: king d. Front Immunol. 2021 Mar 11;12:634832. doi: 10.3389/fimmu.2021.634832. eCollection 2021. Front Immunol. 2021. PMID: 33777023 Free PMC article.
Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection.
Macharia GN, Yue L, Staller E, Dilernia D, Wilkins D, Song H, McGowan E, King D, Fast P, Imami N, Price MA, Sanders EJ, Hunter E, Gilmour J. Macharia GN, et al. Among authors: king d. PLoS Pathog. 2020 Sep 4;16(9):e1008853. doi: 10.1371/journal.ppat.1008853. eCollection 2020 Sep. PLoS Pathog. 2020. PMID: 32886726 Free PMC article.
A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens.
Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth PM, Chung AW, Kent SJ, Held K, Geldmacher C, Dally L, Santos NS, Cole T, Gilmour J, Fidler S, Shattock RJ. Kratochvil S, et al. Among authors: king d. Front Immunol. 2017 May 24;8:595. doi: 10.3389/fimmu.2017.00595. eCollection 2017. Front Immunol. 2017. PMID: 28596770 Free PMC article.
4,420 results